Pyrazolopyrimidine metabolism in Leishmania and trypanosomes: significant differences between host and parasite.
The pathogenic hemoflagellates of the genera Leishmania and Trypanosoma are major causes of human disease in the tropical and subtropical areas of the world. In general, the agents used to treat diseases caused by these organisms are toxic and not suitable for administration to the millions of people infected. Investigations over the past several years have shown that there are several major differences between man and these protozoans with respect to purine metabolism. The differences appear to offer promise for the development of effective chemotherapeutic compounds. These organisms do not synthesize purines de novo, as does man. They are able to concentrate pyrazolopyrimidines with the cell and metabolize them as purines through the salvage pathways, ultimately incorporating them into nucleic acids. This does not occur in mammals. The pyrazolopyrimidine base allopurinol, which has served as a prototype, is activated by a phosphoribosyltransferase to the ribonucleotide. The ribonucleotide is aminated to the 4-amino-pyrazolopyrimidine ribonucleotide and subsequently phosphorylated to the triphosphate form and incorporated into RNA. The pyrazolopyrimidine ribonucleosides formycin B and allopurinol ribonucleoside are activated through a nucleoside phosphotransferase. The resulting ribonucleotide is aminated and incorporated into RNA as described above. These metabolic peculiarities occur not only in the forms of these parasites which are found in the insect vectors but also in the intracellular forms which are pathogenic in man. The differences in the enzymology and metabolism of purines which exist in the genera Leishmania and Trypanosoma offer excellent opportunities for chemotherapeutic exploitation.
D000225:Adenine / Q000031:analogs & derivatives / Q000378:metabolism; D000493:Allopurinol / Q000031:analogs & derivatives* / Q000378:metabolism*; D000818:Animals; D005573:Formycins / Q000378:metabolism; D006790:Host-Parasite Interactions; D007891:Leishmania / Q000378:metabolism*; D012263:Ribonucleosides / Q000378:metabolism*; D013872:Thionucleosides / Q000378:metabolism; D014349:Trypanosoma cruzi / Q000378:metabolism*
D005573:Formycins; D012263:Ribonucleosides; D013872:Thionucleosides; C034561:formycin B; C004420:4-aminopyrazolo(3,4-d)pyrimidine; C033494:thiopurinol ribonucleoside; D000493:Allopurinol; C005832:tisopurine; D000225:Adenine; C021958:allopurinol riboside